Point Biopharma Global Inc (PNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1995 | 12-1994 | 12-1993 | 12-1992 | 12-1991 | |
| Assets | |||||
| Current Assets | |||||
| Other current assets | 18,417 | 26,850 | 30,913 | 13,762 | 13,561 |
| TOTAL | $18,417 | $26,850 | $30,913 | $13,762 | $13,561 |
| Non-Current Assets | |||||
| PPE Net | 219,013 | N/A | 546,890 | 512,299 | 467,442 |
| Investments And Advances | 0 | 6,882 | 16,694 | 31,576 | 2,798 |
| Other Non-Current Assets | 239,908 | 94,424 | 80,159 | 26,322 | 22,591 |
| TOTAL | $458,921 | $101,306 | $643,743 | $570,197 | $492,831 |
| Total Assets | $477,338 | $128,156 | $674,656 | $583,959 | $506,392 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 116,081 | 3,810 | 38,664 | 39,085 | 82,480 |
| Accounts payable and accrued liabilities | 18,531 | 17,781 | 23,286 | 24,272 | 21,752 |
| Accrued Expenses | 6,078 | 11,024 | 7,763 | 8,735 | 8,629 |
| TOTAL | $155,364 | $39,209 | $79,109 | $78,326 | $128,779 |
| Non-Current Liabilities | |||||
| TOTAL | $64,114 | $137,176 | $122,845 | $68,197 | $65,588 |
| Total Liabilities | $219,478 | $176,385 | $201,954 | $146,523 | $194,367 |
| Shareholders' Equity | |||||
| Common Shares | 57,843 | 55,539 | 54,140 | 41,315 | 27,417 |
| Other shareholders' equity | 0 | 2,515 | 0 | 0 | 0 |
| TOTAL | $107,592 | $103,547 | $97,145 | $64,338 | $36,544 |
| Total Liabilities And Equity | $327,070 | $279,932 | $299,099 | $210,861 | $230,911 |